BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30515170)

  • 41. Clinical and Genetic Heterogeneity of
    Israel L; Mellett M
    Front Immunol; 2018; 9():2239. PubMed ID: 30386326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.
    Lamason RL; McCully RR; Lew SM; Pomerantz JL
    Biochemistry; 2010 Sep; 49(38):8240-50. PubMed ID: 20799731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
    Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
    Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B.
    Bertin J; Wang L; Guo Y; Jacobson MD; Poyet JL; Srinivasula SM; Merriam S; DiStefano PS; Alnemri ES
    J Biol Chem; 2001 Apr; 276(15):11877-82. PubMed ID: 11278692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.
    Jattani RP; Tritapoe JM; Pomerantz JL
    J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.
    Wegener E; Oeckinghaus A; Papadopoulou N; Lavitas L; Schmidt-Supprian M; Ferch U; Mak TW; Ruland J; Heissmeyer V; Krappmann D
    Mol Cell; 2006 Jul; 23(1):13-23. PubMed ID: 16818229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome.
    Meininger I; Krappmann D
    Biol Chem; 2016 Dec; 397(12):1315-1333. PubMed ID: 27420898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
    Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural insights into the assembly of CARMA1 and BCL10.
    Li S; Yang X; Shao J; Shen Y
    PLoS One; 2012; 7(8):e42775. PubMed ID: 22880103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.
    Ginster S; Bardet M; Unterreiner A; Malinverni C; Renner F; Lam S; Freuler F; Gerrits B; Voshol J; Calzascia T; Régnier CH; Renatus M; Nikolay R; Israël L; Bornancin F
    PLoS One; 2017; 12(1):e0169026. PubMed ID: 28052131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells.
    Rigo M; Chentouf M; Pèlegrin A; Chardès T
    Cell Immunol; 2011; 270(1):40-6. PubMed ID: 21489413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
    Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
    Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Germline CBM-opathies: From immunodeficiency to atopy.
    Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
    J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CARD19, the protein formerly known as BinCARD, is a mitochondrial protein that does not regulate Bcl10-dependent NF-κB activation after TCR engagement.
    Rios KE; Kashyap AK; Maynard SK; Washington M; Paul S; Schaefer BC
    Cell Immunol; 2020 Oct; 356():104179. PubMed ID: 32763502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.
    Zhang YY; Peng J; Luo XJ
    Biochem Pharmacol; 2022 Apr; 198():114977. PubMed ID: 35218741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of individual domains contributing to MALT1 dimerization in BCL10-independent and dependent assembly.
    Kuo BJ; Lin SC; Tu YF; Huang PH; Lo YC
    Biochem Biophys Res Commun; 2024 Jul; 717():150029. PubMed ID: 38714015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.
    Oikawa D; Hatanaka N; Suzuki T; Tokunaga F
    Front Immunol; 2020; 11():601926. PubMed ID: 33329596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation.
    Eitelhuber AC; Warth S; Schimmack G; Düwel M; Hadian K; Demski K; Beisker W; Shinohara H; Kurosaki T; Heissmeyer V; Krappmann D
    EMBO J; 2011 Feb; 30(3):594-605. PubMed ID: 21157432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.